From: The influence of leukocytospermia on the outcomes of assisted reproductive technology
 | ICSI procedure | ||
---|---|---|---|
 | Group I Leukocytospermia | Group II Non-leukocytospermia | P value |
Cycles | 25 | 25 | Â |
Leukocytes in semen (x106) (mean ± SD) | 2.4 ± 1.7 (1–8) | <1 |  |
Female age (years) | 34.4 ± 3.8 | 34.5 ± 3.6 | >0.99 |
Male age (years) | 37.27 ± 5.0 | 36.7 ± 5.0 | 0.71 |
Aetiology (%) | Â | Â | 0.41 |
Male | 56% (14/25) | 40% (10/25) | Â |
Idiopathic | 16% (4/25) | 16% (4/25) | Â |
Tuboperitoneal | 12% (3/25) | 8% (2/25) | Â |
Endometriosis | 8% (2/25) | 28% (7/25) | Â |
Tuboperitoneal + endometriosis | 4% (1/25) | 8% (2/25) |  |
Male + tuboperitoneal | 4% (1/25) | ---- |  |
Semen parametersa (mean ± SD) |  |  |  |
Total sperm count (x106/mL) | 43.2 ± 44.5 | 69.7 ± 51.5 | 0.06 |
Motility (% spermatozoa) | 35.8 ± 17.8 | 50.7 ± 17.9 | 0.005 |
-rapid + slow progression | 11.9 ± 12.3 | 11.2 ± 10.3 | 0.72 |
-non-progressive | 50.4 ± 23.6 | 35.9 ± 13.6 | 0.0069 |
-immotile Morphology | Â | Â | 0.06 |
-normal forms (%) | 10.1 ± 0.8 | 17.9 ± 20.3 | 0.68 |
Vitality (%) | 45.1 ± 17.5 | 48.8 ± 20.9 | 0.72 |
Metaphase II oocytes (n) | 8.5 ± 4.2 | 7.3 ± 4.2 | 0.32 |
Fertilisation rate (%) | 57.9 ± 30.2 | 61.9 ± 27.7 | 0.74 |
Embryos transfer (n) | 2.2 ± 0.9 | 2.1 ± 1.0 | 0.60 |
Implantation rate (%) | 12.3% (7/54) | 13.5% (7/52) | 0.93 |
Pregnancy/cycle (%) | 24% (6/25) | 24% (6/25) | 1 |
Miscarriage (%) | 0 | 0 | Â |
Ongoing pregnancy/cycle (%) | 24% (6/25) | 24% (6/25) | 1 |
Live birth/cycle (%) | 24% (6/25) | 24% (6/25) | 1 |